Liquid Biopsy Market Expected to Reach US$ 94.29 Billion by 2033
The liquid biopsy market plays a vital role in advancing cancer care by providing accessible, repeatable diagnostic testing that supports earlier detection and more responsive treatment management. Diagnostics developers are increasingly focusing on improving assay sensitivity, next-generation sequencing throughput, and clinical validation to meet evolving oncology demands. As healthcare...
0 Comentários 0 Compartilhamentos 69 Visualizações 0 Anterior